>>> Pershing Square discloses updated portfolio positions in 13F fi Pershing Square discloses updated portfolio positions in 13F filing: New ~1.35 mln share position in Actavis (ACT) and new ~19.5 mln share position in Valeant Pharmaceuticals (VRX)